First To Know
Buy The Test

First To Know

In the news

  • Press Releases May 28, 2026

    NOWDiagnostics Appoints Lisa Nibauer as Chief Executive Officer to Lead Next Phase of Innovation and Transformation

    Proven Leader in Transforming MedTech Businesses and Delivering Innovation Across Consumer and Point-of-Care Testing to Accelerate Company’s Next Phase SPRINGDALE, Ark. – May 28, 2026 – NOWDiagnostics, Inc., a leader in innovative rapid diagnostic testing, today announced the appointment of Lisa A. Nibauer as Chief Executive Officer. Nibauer brings more than 25 years of healthcare…

    Read More

  • Press Releases January 22, 2025

    First To Know – the only Over-the-Counter Home Test for Syphilis – Will Now Be Available Through the National Alliance of State and Territorial AIDS Directors, Building Healthy Online Communities and the TakeMeHome Initiative

    – Program Provides At-Risk Consumers Access to Free Tests Delivered At Home –   SPRINGDALE, ARK. – January 22, 2025 – NOWDiagnostics, Inc. (NOWDx), a leader in developing over-the-counter (OTC) and point-of-care (POC) diagnostic tests, proudly announces that its First To Know® Syphilis Test has joined the innovative TakeMeHome initiative. In collaboration with NASTAD (National Alliance…

    Read More

  • Press Releases January 07, 2025

    NOWDiagnostics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

    CEO Robert Weigle to share NOWDx’s vision for transforming consumer healthcare through in-home testing with results in minutes, and highlight commitment to advancing OTC and POC diagnostic products, including novel FDA-authorized First To Know Syphilis Test.

    Read More

  • Press Releases November 19, 2024

    First and Only In-Home Test for Syphilis Now Available to Consumers through Major Retailers and Public Health: NOWDiagnostics Launches First To Know Syphilis Test Across the U.S.

    With syphilis cases on the rise, NOWDx’s over-the-counter test offers rapid, in-home results in minutes and is now available nationwide in thousands of pharmacies, retail, and drugstore locations and on Amazon SPRINGDALE, Ark. – November 19, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that its First…

    Read More

  • Press Releases October 16, 2024

    NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.

    As syphilis cases surge nationwide, the collaboration will bring the First To Know over-the-counter test to clinicians and patients across professional and hospital settings NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that Labcorp, a global leader of innovative and comprehensive laboratory services, will be the exclusive U.S. distributor…

    Read More

  • Press Releases August 16, 2024

    NOWDiagnostics First To Know Syphilis Test Receives FDA De Novo Marketing Authorization for Over-the-Counter Use

    First and only rapid syphilis test with in-home results in minutes, addressing growing epidemic SPRINGDALE, ARK. – August 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization to its First To Know® Syphilis Test for…

    Read More